Back to Search
Start Over
Imaging paclitaxel (chemotherapy)-induced tumor apoptosis with 99mTc C2A, a domain of synaptotagmin I: a preliminary study.
- Source :
-
Nuclear medicine and biology [Nucl Med Biol] 2008 Apr; Vol. 35 (3), pp. 359-64. - Publication Year :
- 2008
-
Abstract
- Purpose: To evaluate the dynamics and feasibility of imaging non-small cell lung cancer (NSCLC) apoptosis induced by paclitaxel treatment using 99mTc-labeled C2A domain of synaptotagmin I in a mouse model.<br />Materials and Methods: H460 tumor-bearing mice were treated with intravenous paclitaxel, and 12, 24, 48 and 72 h later, 99mTc-C2A-GST was injected intravenously, and planar images were acquired at 2, 4 and 6 h postinjection on a dual-head gamma camera fitted with a pinhole collimator. Tumor-to-normal tissue ratios (T/NT) were calculated by ROI analysis and reflected specific binding of 99mTc-C2A-GST. Mice were sacrificed after 6-h imaging; caspase-3 as apoptosis executer was determined by flow cytometry; DNA fragmentation was analyzed by terminal deoxynucleotidytransferase mediated dUTP nick-end labeling (TUNEL) assay. Whereas nonspecific accumulation was estimated using inactivated C2A-GST. The imaging data were correlated with TUNEL-positive nuclei and caspase-3 activity.<br />Results: T/NT significantly increased after paclitaxel inducement, whereas it was low in untreated tumors (T/NT=1.24+/-0.23). In terms of % ID/g, activity in Group 2 (12 h), Group 3 (24 h), Group 4 (48 h) and Group 5 (72 h) after the treatment was 2.05+/-0.20, 3.02+/-1.01, 3.17+/-1.16 and 3.96+/-1.72, respectively. Whereas in the nontreated group, Group 1 % ID/g was 1.21+/-0.51. The radiotracer uptake was positively correlated to the apoptotic index (r=0.70, P<.01), as well as caspase-3 activity (r=0.75, P<.01).<br />Conclusion: This study addresses the dynamics and feasibility of imaging non-small cell lung tumor apoptosis using 99mTc-labeled C2A.
- Subjects :
- Animals
Antineoplastic Agents, Phytogenic therapeutic use
Carcinoma, Non-Small-Cell Lung drug therapy
Caspase 3 drug effects
Caspase 3 metabolism
Cell Line, Tumor
DNA Fragmentation drug effects
Disease Models, Animal
Female
Humans
Injections, Intravenous
Lung Neoplasms drug therapy
Male
Mice
Protein Structure, Tertiary
Radioligand Assay methods
Radionuclide Imaging
Radiopharmaceuticals pharmacokinetics
Synaptotagmin I drug effects
Tissue Distribution
Apoptosis drug effects
Carcinoma, Non-Small-Cell Lung diagnostic imaging
Lung Neoplasms diagnostic imaging
Paclitaxel therapeutic use
Synaptotagmin I chemistry
Technetium pharmacokinetics
Subjects
Details
- Language :
- English
- ISSN :
- 0969-8051
- Volume :
- 35
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Nuclear medicine and biology
- Publication Type :
- Academic Journal
- Accession number :
- 18355692
- Full Text :
- https://doi.org/10.1016/j.nucmedbio.2007.12.007